Ulcerative Colitis Market Set for $10.8B Surge by 2030, Fueled by Drug Innovation and Rising Global Demand

https://www.alliedmarketresearch.com/ulcerative-colitis-market

The global ulcerative colitis market, valued at $6.2 billion in 2020, is projected to grow to $10.8 billion by 2030, registering a CAGR of 5.7% from 2021 to 2030. Ulcerative colitis, a common form of inflammatory bowel disease (IBD), leads to inflammation and ulcers in the digestive tract, primarily affecting the large intestine. Although this condition can develop at any age, it is most prevalent in individuals aged 15 to 30. Symptoms vary widely but often include diarrhea, bloody stools, and abdominal pain due to an abnormal immune response.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/3965

Key Market Drivers

1. Prevalence of Inflammatory Gastrointestinal Disorders: Increasing cases of ulcerative colitis worldwide are a primary growth driver for the market. For instance, a 2019 survey by Marc D. Basson reported over one million cases of ulcerative colitis in the U.S. alone. As the burden of inflammatory bowel diseases rises, the demand for treatment options is also increasing.
2. Advancements in Drug Development: The market is experiencing rapid growth due to the development of new treatments. In May 2021, Bristol Myers Squibb received U.S. FDA approval for Zeposia, a drug targeting moderate to severe ulcerative colitis. Such advancements are opening new opportunities in the ulcerative colitis market.
3. Regional Insights: North America, which dominated the market in 2020, continues to be a strong player, driven by a robust healthcare system, key market players, and ongoing drug innovations. However, the Asia-Pacific region is expected to register the highest growth rate of 6.5% during the forecast period due to increasing healthcare infrastructure and rising incidences of gastrointestinal diseases.

Market Segmentation

1. By Route of Administration: The market is divided into oral and injectable treatments. Oral medications dominated the market in 2020 due to the rise in demand for non-invasive therapies. However, injectables are expected to witness considerable growth owing to the increasing number of ulcerative colitis cases.
2. By Disease Type: The market is segmented into mild, moderate, and severe ulcerative colitis. Mild ulcerative colitis dominated the market in 2020, attributed to the increasing prevalence of IBD. Moderate cases, however, are expected to see the fastest growth, driven by advancements in drug development and clinical trials.
3. By Molecule Type: The market is categorized into small molecules and biologics. Small molecules held the majority share in 2020 due to their widespread use and availability. However, biologics are projected to witness significant growth, fueled by their effectiveness in treating gastrointestinal inflammation.

Regional Outlook
• North America remains the dominant market for ulcerative colitis treatments, thanks to the presence of top pharmaceutical companies and a strong healthcare sector.
• Asia-Pacific is anticipated to experience the highest CAGR during the forecast period due to rising healthcare investments, improved infrastructure, and increasing awareness of gastrointestinal diseases.

Key Players
Key players in the global ulcerative colitis market include Abbott Laboratories, Ajinomoto, AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer, and Sanofi. These companies are investing heavily in R&D to develop innovative therapies for ulcerative colitis, contributing to the market's growth.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/3965

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.